These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12584672)
1. Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination. Endsley JJ; Quade MJ; Terhaar B; Roth JA Vet Ther; 2002; 3(4):364-72. PubMed ID: 12584672 [TBL] [Abstract][Full Text] [Related]
2. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle. Platt R; Coutu C; Meinert T; Roth JA Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971 [TBL] [Abstract][Full Text] [Related]
3. BHV-1-Specific CD4+, CD8+, and gammadelta T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine. Endsley JJ; Quade MJ; Terhaar B; Roth JA Viral Immunol; 2002; 15(2):385-93. PubMed ID: 12081020 [TBL] [Abstract][Full Text] [Related]
4. Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela Platt R; Kesl L; Guidarini C; Wang C; Roth JA Vet Immunol Immunopathol; 2017 May; 187():20-27. PubMed ID: 28494925 [TBL] [Abstract][Full Text] [Related]
5. Maternal antibody blocks humoral but not T cell responses to BVDV. Endsley JJ; Roth JA; Ridpath J; Neill J Biologicals; 2003 Jun; 31(2):123-5. PubMed ID: 12770543 [TBL] [Abstract][Full Text] [Related]
7. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine. Xue W; Mattick D; Smith L; Maxwell J Can J Vet Res; 2009 Oct; 73(4):292-7. PubMed ID: 20046631 [TBL] [Abstract][Full Text] [Related]
8. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid. Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641 [TBL] [Abstract][Full Text] [Related]
9. Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge. Platt R; Widel PW; Kesl LD; Roth JA Vaccine; 2009 Jul; 27(33):4508-19. PubMed ID: 19446589 [TBL] [Abstract][Full Text] [Related]
10. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves. Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841 [TBL] [Abstract][Full Text] [Related]
12. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330 [TBL] [Abstract][Full Text] [Related]
13. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation. Ficken MD; Ellsworth MA; Tucker CM; Cortese VS J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126 [TBL] [Abstract][Full Text] [Related]
14. Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers. Downey-Slinker ED; Ridpath JF; Sawyer JE; Skow LC; Herring AD Vaccine; 2016 Sep; 34(42):5053-5059. PubMed ID: 27601344 [TBL] [Abstract][Full Text] [Related]
15. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus. Xue W; Mattick D; Smith L Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076 [TBL] [Abstract][Full Text] [Related]
16. Measuring CMI responses using the PrimeFlow RNA assay: A new method of evaluating BVDV vaccination response in cattle. Falkenberg SM; Dassanayake RP; Neill JD; Walz PH; Casas E; Ridpath JF; Roth J Vet Immunol Immunopathol; 2020 Mar; 221():110024. PubMed ID: 32070831 [TBL] [Abstract][Full Text] [Related]
17. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2. Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338 [TBL] [Abstract][Full Text] [Related]
18. Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle. Sadat SMA; Snider M; Garg R; Brownlie R; van Drunen Littel-van den Hurk S Vaccine; 2017 Jun; 35(27):3466-3473. PubMed ID: 28527686 [TBL] [Abstract][Full Text] [Related]
19. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine. Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830 [TBL] [Abstract][Full Text] [Related]
20. The Occurrence of a Commercial N Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M Viruses; 2018 May; 10(5):. PubMed ID: 29783722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]